In the recent exchanges in the private equity industry, the pharmaceutical sector has risen quietly and has become a hot spot in the near future. Some manufacturers of high-tech preparation products and specialty APIs have become high-quality resources in the eyes of private equity fund managers.

In an atmosphere where high-quality resources are already scarce, the movement of funds into the pharmaceutical industry is more rapid and has a strong purpose.

A necessary investment portfolio, accelerated deployment of private equity venture capital

When talking about the current environment in China, Bei Xiang, president and founding partner of Beixiang Investment Group, said that this is the best period for private enterprises in China. He pointed out, "There are many international businessmen who want to come to China to support China's small and medium-sized enterprises. Small and medium-sized private enterprises are much better developed in China than in other countries." For the investment field, Bei Xiang said that medical, education and consumer In the field, there are the best investment opportunities in China.

After building a professional team in the pharmaceutical industry and successfully raising funds for the pharmaceutical industry, Kunwu Jiuding Investment Management Co., Ltd. (hereinafter referred to as Jiuding Investment) followed its consistent style of high efficiency, professionalism, and independence, and frequently shot in the pharmaceutical industry recently. Shortly after injecting 34 million yuan into Haikou Qili Pharmaceutical Co., Ltd. through its fund at the end of March, Jiuding Investment once again shot in the pharmaceutical industry in early April, injecting capital into Shanxi Pude Pharmaceutical Co., Ltd. (hereinafter referred to as Pude Pharmaceutical) 11 Ten million yuan, all funds have been received. After more than 9 months of long-term "love", Pude Pharmaceutical and Jiuding Investment finally succeeded in "holding hands".

"Our contact and research with Pude Pharmaceutical started as early as June 2009, followed by continuous research and negotiation, and even acted as a process for shareholders to provide value-added services in advance. During this period, we experienced a lot of discussions and finally achieved positive results. Said Yu Bo, a partner at Jiuding Investment.

"Actually, we don't lack money, but Jiuding Investment's deep understanding of the pharmaceutical industry and the value-added service system provided by pharmaceutical companies make the final cooperation successful." Hu Chengwei, chairman of Shanxi Pude Pharmaceutical, said. After the first meeting between the two parties, Pude Pharmaceutical left the Jiuding team with an "operation"-giving professional advice on the investment value of the 2 pharmaceutical projects. The professional reply from Jiuding Investment one week later knocked on the door of Pude Pharmaceutical to introduce strategic investors and officially opened the cooperation process between the two parties.

Zhao Ying, an investment advisory and management partner of American Pilot Fund, once pointed out that private equity has frequently shot in the field of medicine, and the layout has already begun.

Recent investment cases also include Chongqing Detong Fund investing US $ 10 million in Chongqing Boteng Fine Chemical Co., Ltd., One Equity Partners, a private equity investment company owned by JPMorgan Chase, invested US $ 69.6 million in Guangzhou Concaine Pharmaceuticals and SoftBank China Venture Capital Suzhou Natong Bio-Nanotech Co., Ltd., NEA and BioVida restructured Nescacon Pharmaceuticals, venture capital firm Siwei Anhong invested US $ 7 million in the first round of capital injection into Anhui Anqing Pharmaceutical Company, etc. The medical and pharmaceutical industry has become an indispensable part of most venture capital and private equity investment portfolios.

With the establishment of the country's strategic positioning for emerging industries, venture capital and private equity investment institutions are booming in this area. It is understood that in 2009, venture capital and private equity investment institutions in the information industry, new energy industry, new materials industry, pharmaceutical / health products, bioengineering and other strategic emerging industries have 307 investment cases, with an investment amount of 1.88 billion US dollars.

Judging from the investment progress of each season, the layout of venture capital and private equity investment institutions in strategic emerging industries is accelerating, especially after the three strategic emerging industry development seminars in the third quarter of last year, the fourth quarter is There were 105 strategic emerging industry investments, involving an amount of US $ 699 million, which accounted for 34.2% of the total investment cases and 37.2% of the total investment. The number of investment cases increased by 21 compared with the third quarter, and the investment increased by 85.6%.

Local funding preference, the test is even after "taking medicine"

Due to different investment preferences and influenced by the exit mechanism, Chinese and foreign investment institutions have different investment layout characteristics in strategic emerging industries. Overall, the number and amount of investments by local venture capital and private equity investment institutions in strategic emerging industries in 2009 exceeded that of foreign venture capital and private equity investment institutions. Among them, there were 185 local venture capital and private equity investment cases. , Accounting for 60.3% of the total proportion; the investment amount is 963 million US dollars, accounting for 51.3% of the overall proportion.

In terms of specific strategic emerging industry layouts, local and foreign venture capital and private equity investment institutions also exhibit different characteristics. The report of Zero2IPO Research Center shows that foreign venture capital and private equity investment institutions have a larger proportion of investment in the Internet field. For the Internet of Things, new energy, environmental protection, pharmaceutical and biological industries, local venture capital and private equity investment institutions are investing The number of enterprises still has a clear advantage in terms of amount.

Of course, for the domestic private equity fund of "Hi Medicine", the current generosity is also the result of careful research in the early stage. For professional and prudent investors, handshake is just the beginning of cooperation, and the process of research, negotiation and implementation of various value-added services in the next few months or even years is also very important. "This is a test of the professional competence and spirit of cooperation of both parties," Yu Bo said. "It is also because of lasting and in-depth research and negotiation that each other's understanding is constantly deepening, and this is the basis of in-depth cooperation."

However, the capital injection is only the beginning, and the subsequent work will test the management level of the capital. It is also difficult for capital to do a good job of "medicine". Looking forward, Yu Bo also said that with the further improvement of the personnel structure of Jiuding Investment's pharmaceutical professional team, Jiuding Investment will provide support for Pude Pharmaceutical in capital operation and industrial competition. On the basis of continuation of past competitive advantages, Pude Pharmaceutical also needs to embark on a more solid path in the derivation of the industrial chain, the improvement of product varieties, and the expansion of production scale.

The above information source "Venture Investment" is authorized by the China Venture Capital Research Institute (CVCRI) to publish it. All rights reserved. Please indicate the source when reprinting. For more information, please click download to view all articles.
For more information, please refer to Guotaian Financial Education Group Guotaian Education Service Network Contact E-mail:

Window Scraper

Professional window cleaner squeeegee

High Window Scraper

The window cleaning kit has 4 extension poles that can be freely assembled. Can provide 62in distance, which can easily help you reach high windows.

Indoor and outdoor windows

Handheld state, you can fully use the flexible spring, more flexible, better cleaning effect, it is recommended to follow the S-shaped wipe.

Car Window Cleaning Brush

The long pole can clean the roof and windshield of large trucks better, and the handheld short pole can easily wipe the glass on both sides of the car.

Bathroom Cleaning

Scratch-Free squeegee super cleaning ability, can easily clean mirrors, bathroom glass doors, giving you a shiny mirror.

Window Cleaning Supplies

The window squeegee and scraper can also be used by hand to easily wash a clean lower-level glasses. The 4-stage extension poles is sturdy enough and light weight can effectively avoid the pressure of the telescopic pole on the arm, reduce the labor weight.

If you're like most people, cleaning the inside and outside of windows can be a chore. The 2-in-1 Best Window Scraper can give you a comfortable cleaning experience.

Window Scraper,Window Scraper Blade,Best Window Scraper,Plastic Window Scraper

NINGBO NEWMORE IMP. & EXP. Co., LTD. , https://www.zjnewmore888.com